Basic Sciences
-
Study uses new tools, machine learning to investigate major cause of blindness in older adults
Vanderbilt researchers, in collaboration with investigators from the University of Alabama at Birmingham, the Delft University of Technology, University Hospital Bonn, and Molecular Horizon have developed new protocols to study which molecular pathways might be important in the aging retina and what might cause the formation of deposits in the eye that confer high risk for age-related macular degeneration. Read MoreJan 3, 2024
-
Quanta Magazine: She studies how addiction hijacks learning in the brain
Erin Calipari works to understand how drugs like opioids and cocaine alter learning circuits and neurochemistry in one of the country's epicenters of substance use disorder and addiction. Read MoreDec 14, 2023
-
Vanderbilt Center for Addiction Research joins Discovery Vanderbilt; Calipari appointed director
The Vanderbilt Center for Addiction Research, led by Erin Calipari, advances research to understand how addiction and substance use disorder develops in the brain. VCAR’s goals are to develop new pharmaceutical strategies and to destigmatize addiction as a personal failing. Read MoreDec 14, 2023
-
Kit Neikirk named Marshall Scholar; will study at University of Edinburgh and University College London
As a Marshall Scholar, considered among the most accomplished undergraduates and recent graduates in the U.S., Neikirk will pursue advanced degrees in social determinants of health and biomedical imaging. Read MoreDec 12, 2023
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials. Read MoreDec 4, 2023
-
Warren Center for Neuroscience Drug Discovery added to Discovery Vanderbilt portfolio; philanthropic matching launched
Vanderbilt has announced the addition of the Warren Center for Neuroscience Drug Discovery into Discovery Vanderbilt as well as an initiative within the Dare to Grow campaign to inspire philanthropy with a one-to-one match for gifts of $100,000 or more. Read MoreDec 4, 2023
-
Novel C. diff structures are required for infection, offer new therapeutic targets
Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. Read MoreNov 15, 2023
-
-
Osheroff receives Distinguished Teacher Award from Association of American Medical Colleges
As a professor of biochemistry and medicine at Vanderbilt University School of Medicine for more than 40 years, Osheroff is the longest serving course director currently teaching medical students. He also codirects the preclerkship phase of the medical school curriculum and leads the Master Science Teachers cohort, a role established in 2007 to recognize VUSM’s outstanding basic science educators. Through his teaching, he has helped medical students at VUSM and across the globe acquire the basic science skills and knowledge they need to thrive in clinical practice, according to the AAMC. Read MoreOct 31, 2023
-
Lab-to-Table special event: ‘Hollywood Reimagined with AI,’ a film screening and discussion on Nov. 10
Join “Hollywood Reimagined with AI” in an in-person Lab-to-Table Conversation on November 10 at Sarratt Cinema. Read MoreOct 26, 2023
-
Biochemist Martin Egli elected to the European Academy of Sciences and Arts
For his outstanding achievements, including investigations directed at nucleic acid structure, DNA bypass polymerases and the circadian clock, Martin Egli has been elected to the European Academy of Sciences and Arts. The academy is dedicated to innovative research, interdisciplinary and transnational collaboration. Read MoreOct 25, 2023